Pharma-Cycle has developed and patented technology and procedures to capture, sequester and destroy chemotherapy chemicals found in cancer patients’ human waste. This patented process minimizes exposure for caregivers, family and the environment. We are the only company to offer a solution to this growing problem.
The Company's leadership team are experts in chemical waste disposal, pharmaceuticals and healthcare. The Advisory Team is made up of globally recognized leaders in the fields of bioscience, cutting edge cancer research and go-to-market strategies.
The Drug Quality and Security Act (H.R. 3204) is a new law that amended the Federal Food, Drug, and Cosmetic Act to grant the Food and Drug Administration more authority to regulate and monitor the manufacturing of compounded drugs. It was signed into law in November, 2013.
This act mandated the FDA require United States Pharmacopeia (USP) to set standards for compounding drugs. (USP) 800 which was published in 2017 and took effect December 1, 2019. (USP) 800 forces the control of certain cytotoxic chemotherapy drugs from the time they arrive at the pharmacy all the way through excretion by the patient.
In addition to the federal mandates, the State of Rhode Island Department of Environmental Management amended RI hazardous waste regulations in 2014 and defined a new “extremely hazardous waste” category that includes cytotoxic chemotherapy drugs. The amendment made it illegal to dispose of extremely hazardous waste directly into sewer or septic systems.
Founder and CEO, Jim Mullowney is a well-known leader and scientist in the hazardous waste industry and a pioneer in the field of cytotoxic sanitary waste. He has devoted many years to developing the Pharma-Cycle™ Solution, receiving five patents that place the company front and center in the global fight to make cancer therapy safer. Jim successfully advocated legislation that mandates control of certain cytotoxic chemotherapy drugs from the time they arrive at the pharmacy all the way through excretion by the patient.